Stay updated on Lenvatinib and Pembrolizumab in HCC Clinical Trial

Sign up to get notified when there's something new on the Lenvatinib and Pembrolizumab in HCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lenvatinib and Pembrolizumab in HCC Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page's revision label has been updated from v3.5.2 to v3.5.3. This reflects a minor update to the page's metadata or documentation.
    Difference
    0.0%
    Check dated 2026-04-30T17:23:04.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    Added revision note: v3.5.2; removed revision: v3.5.0.
    Difference
    0.0%
    Check dated 2026-04-16T11:05:03.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    - Padua, Italy, 35128 was replaced by Padova, Italy, 35128 in the locations list.
    Difference
    0.0%
    Check dated 2026-04-09T08:31:06.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    Added the disease term Hepatocellular carcinoma and a Resources section linking to the Genetic and Rare Diseases Information Center. Updated the page revision from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-18T17:48:09.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Added Revision: v3.4.3 and removed Revision: v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-11T16:56:09.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    Plain Language Summary added and page updated to Revision 3.4.2 with new dates; funding-status notice removed.
    Difference
    0.3%
    Check dated 2026-02-11T09:21:20.000Z thumbnail image

Stay in the know with updates to Lenvatinib and Pembrolizumab in HCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lenvatinib and Pembrolizumab in HCC Clinical Trial page.